HeimDEVA • IST
add
Deva Holding AS
Við síðustu lokun
67,10 ₺
Dagbil
66,10 ₺ - 68,00 ₺
Árabil
51,00 ₺ - 81,75 ₺
Markaðsvirði
13,41 ma. TRY
Meðalmagn
637,03 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
IST
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (TRY) | des. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 5,49 ma. | -2,19% |
Rekstrarkostnaður | 1,74 ma. | 2,67% |
Nettótekjur | -1,34 ma. | -524,24% |
Hagnaðarhlutfall | -24,48 | -537,50% |
Hagnaður á hvern hlut | — | — |
EBITDA | 622,26 m. | -48,71% |
Virkt skatthlutfall | -294,28% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (TRY) | des. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 3,59 ma. | 26,49% |
Heildareignir | 37,63 ma. | -3,31% |
Heildarskuldir | 11,31 ma. | -3,14% |
Eigið fé alls | 26,32 ma. | — |
Útistandandi hlutabréf | 200,02 m. | — |
Eiginfjárgengi | 0,51 | — |
Arðsemi eigna | -0,61% | — |
Ávöxtun eigin fjár | -0,70% | — |
Peningaflæði
Breyting á handbæru fé
| (TRY) | des. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | -1,34 ma. | -524,24% |
Handbært fé frá rekstri | 1,49 ma. | 27,32% |
Reiðufé frá fjárfestingum | -838,87 m. | -130,98% |
Reiðufé frá fjármögnun | 260,62 m. | 117,90% |
Breyting á handbæru fé | 885,62 m. | 206,74% |
Frjálst peningaflæði | -165,38 m. | 95,31% |
Um
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market.
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries.
Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
Stofnsett
22. sep. 1958
Vefsvæði
Starfsfólk
3.023
